Study on Treatment Resistant Depression
This study looks at how a medicine called BPL-003 can help people who have treatment resistant depression (TRD). TRD means that a person has tried two or more medicines for depression, but they didn't work. In this study, 225 people will get one dose of BPL-003 through the nose. They will get a low, medium, or high dose. After taking the medicine, there will be 8 weeks of check-ups. Participants will also receive psychological support, which means they will talk to someone who will help them feel better before, during, and after taking the medicine.
Key Points:
- This study lasts for 8 weeks with one dose of medicine.
- Participants will need to stop their current depression medicine.
- It's important to not be pregnant and use birth control during the study.
Before joining, you need to make sure you meet the requirements, like having TRD and not having certain mental health conditions. It's important to have a talk with your doctor to see if this study is right for you.